{"transactions":[{"id":699965,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-07-31T20:34:49.000Z","date":"2026-07-29","kind":"gift","planned":false,"acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involves a bona fide gift of securities from the reporting person to a donor advised fund."}],"balance_after":7172,"source":{"system":"sec-edgar","filing":"0001337798-26-000004","document":"form4-07312026_080745.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000133779826000004/form4-07312026_080745.xml","form_type":"4"}},{"id":699964,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-07-31T20:34:49.000Z","date":"2026-07-29","kind":"sale","planned":false,"acquired":false,"shares":3673,"price":81.43,"value":299092.39,"ownership":{"direct":true},"balance_after":11672,"source":{"system":"sec-edgar","filing":"0001337798-26-000004","document":"form4-07312026_080745.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000133779826000004/form4-07312026_080745.xml","form_type":"4"}},{"id":754840,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-02T20:42:51.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":false,"shares":2799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2799},"source":{"system":"sec-edgar","filing":"0001337798-26-000002","document":"form4-06022026_080647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000133779826000002/form4-06022026_080647.xml","form_type":"4"}},{"id":754839,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-02T20:42:51.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":2026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."}],"balance_after":2026,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2026},"source":{"system":"sec-edgar","filing":"0001337798-26-000002","document":"form4-06022026_080647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000133779826000002/form4-06022026_080647.xml","form_type":"4"}},{"id":754838,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2026-06-02T20:42:51.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":12158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."}],"balance_after":12158,"derivative":{"exercise_price":48.38,"expiration_date":"2036-05-28","underlying":"Class A Ordinary Shares","underlying_shares":12158},"source":{"system":"sec-edgar","filing":"0001337798-26-000002","document":"form4-06022026_080647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000133779826000002/form4-06022026_080647.xml","form_type":"4"}},{"id":754837,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-06-02T20:42:51.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":true,"shares":2799,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":15345,"source":{"system":"sec-edgar","filing":"0001337798-26-000002","document":"form4-06022026_080647.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000133779826000002/form4-06022026_080647.xml","form_type":"4"}},{"id":756936,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-01T20:43:15.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":11766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 28, 2027, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of\nthe grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 28, 2027, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of\nthe grant."}],"balance_after":11766,"derivative":{"underlying":"Common Stock","underlying_shares":11766},"source":{"system":"sec-edgar","filing":"0001447362-26-000013","document":"wk-form4_1780346592.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736226000013/wk-form4_1780346592.xml","form_type":"4"}},{"id":761654,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-27T20:20:50.000Z","date":"2026-05-22","kind":"exercise","planned":false,"acquired":false,"shares":13667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 22, 2026, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of\nthe grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 22, 2026, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of\nthe grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":13667},"source":{"system":"sec-edgar","filing":"0001447362-26-000011","document":"wk-form4_1779913247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736226000011/wk-form4_1779913247.xml","form_type":"4"}},{"id":761653,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-27T20:20:50.000Z","date":"2026-05-22","kind":"exercise","planned":false,"acquired":true,"shares":13667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."}],"balance_after":32976,"source":{"system":"sec-edgar","filing":"0001447362-26-000011","document":"wk-form4_1779913247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736226000011/wk-form4_1779913247.xml","form_type":"4"}},{"id":853418,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-03-09T20:12:43.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":false,"shares":4748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested."}],"balance_after":20000,"derivative":{"exercise_price":3.38,"expiration_date":"2029-03-11","underlying":"Common Stock","underlying_shares":4748},"source":{"system":"sec-edgar","filing":"0001447362-26-000008","document":"wk-form4_1773087160.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736226000008/wk-form4_1773087160.xml","form_type":"4"}},{"id":853417,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-09T20:12:43.000Z","date":"2026-03-05","kind":"sale","planned":false,"acquired":false,"shares":2655,"price":28.51,"value":75694.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $28.47 to $28.57, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":19309,"source":{"system":"sec-edgar","filing":"0001447362-26-000008","document":"wk-form4_1773087160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736226000008/wk-form4_1773087160.xml","form_type":"4"}},{"id":853416,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-09T20:12:43.000Z","date":"2026-03-05","kind":"sale","planned":false,"acquired":false,"shares":4748,"price":28.44,"value":135033.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $28.39 to $28.51, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":21964,"source":{"system":"sec-edgar","filing":"0001447362-26-000008","document":"wk-form4_1773087160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736226000008/wk-form4_1773087160.xml","form_type":"4"}},{"id":853415,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-09T20:12:43.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":true,"shares":4748,"price":3.38,"value":16048.24,"ownership":{"direct":true},"balance_after":26712,"source":{"system":"sec-edgar","filing":"0001447362-26-000008","document":"wk-form4_1773087160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736226000008/wk-form4_1773087160.xml","form_type":"4"}},{"id":1121419,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-05T21:07:41.000Z","date":"2025-06-05","kind":"exercise","planned":false,"acquired":false,"shares":3173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested in a single installment on June 5, 2025; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested in a single installment on June 5, 2025; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":3173},"source":{"system":"sec-edgar","filing":"0001415889-25-015805","document":"form4-06052025_090634.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015805/form4-06052025_090634.xml","form_type":"4"}},{"id":1121418,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-05T21:07:41.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":2799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025."}],"balance_after":2799,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2799},"source":{"system":"sec-edgar","filing":"0001415889-25-015805","document":"form4-06052025_090634.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015805/form4-06052025_090634.xml","form_type":"4"}},{"id":1121417,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2025-06-05T21:07:41.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":16798,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025."}],"balance_after":16798,"derivative":{"exercise_price":29.11,"expiration_date":"2035-06-02","underlying":"Class A Ordinary Shares","underlying_shares":16798},"source":{"system":"sec-edgar","filing":"0001415889-25-015805","document":"form4-06052025_090634.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015805/form4-06052025_090634.xml","form_type":"4"}},{"id":1121416,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2025-06-05T21:07:41.000Z","date":"2025-06-05","kind":"exercise","planned":false,"acquired":true,"shares":3173,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":12546,"source":{"system":"sec-edgar","filing":"0001415889-25-015805","document":"form4-06052025_090634.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015805/form4-06052025_090634.xml","form_type":"4"}},{"id":1135188,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-23T21:01:17.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":13667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 22, 2026, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of\nthe grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 22, 2026, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of\nthe grant."}],"balance_after":13667,"derivative":{"underlying":"Common Stock","underlying_shares":13667},"source":{"system":"sec-edgar","filing":"0001447362-25-000087","document":"wk-form4_1748034070.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736225000087/wk-form4_1748034070.xml","form_type":"4"}},{"id":1135187,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-23T21:01:17.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":false,"shares":8673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 23, 2025, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of\nthe grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 23, 2025, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of\nthe grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8673},"source":{"system":"sec-edgar","filing":"0001447362-25-000087","document":"wk-form4_1748034070.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736225000087/wk-form4_1748034070.xml","form_type":"4"}},{"id":1135186,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-23T21:01:17.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":true,"shares":8673,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."}],"balance_after":21964,"source":{"system":"sec-edgar","filing":"0001447362-25-000087","document":"wk-form4_1748034070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736225000087/wk-form4_1748034070.xml","form_type":"4"}},{"id":1486904,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-06-07T20:41:23.000Z","date":"2024-06-06","kind":"exercise","planned":false,"acquired":false,"shares":4373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested in a single installment on June 6, 2024; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested in a single installment on June 6, 2024; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Common Shares","underlying_shares":4373},"source":{"system":"sec-edgar","filing":"0001415889-24-016009","document":"form4-06072024_080618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924016009/form4-06072024_080618.xml","form_type":"4"}},{"id":1486903,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-06-07T20:41:23.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":3173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary date of the grant, June 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary date of the grant, June 5, 2024."}],"balance_after":3173,"derivative":{"underlying":"Class A Common Shares","underlying_shares":3173},"source":{"system":"sec-edgar","filing":"0001415889-24-016009","document":"form4-06072024_080618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924016009/form4-06072024_080618.xml","form_type":"4"}},{"id":1486902,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2024-06-07T20:41:23.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":19040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant. The date of the grant is June 5, 2024."}],"balance_after":19040,"derivative":{"exercise_price":19.71,"expiration_date":"2034-06-04","underlying":"Class A Common Shares","underlying_shares":19040},"source":{"system":"sec-edgar","filing":"0001415889-24-016009","document":"form4-06072024_080618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924016009/form4-06072024_080618.xml","form_type":"4"}},{"id":1486901,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Share","published_at":"2024-06-07T20:41:23.000Z","date":"2024-06-06","kind":"exercise","planned":false,"acquired":true,"shares":4373,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."}],"balance_after":9373,"source":{"system":"sec-edgar","filing":"0001415889-24-016009","document":"form4-06072024_080618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924016009/form4-06072024_080618.xml","form_type":"4"}},{"id":1499069,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-29T20:43:05.000Z","date":"2024-05-25","kind":"exercise","planned":false,"acquired":false,"shares":8636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on the one-year anniversary of the date of grant on May 25, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on the one-year anniversary of the date of grant on May 25, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8636},"source":{"system":"sec-edgar","filing":"0001447362-24-000094","document":"wk-form4_1717015375.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000094/wk-form4_1717015375.xml","form_type":"4"}},{"id":1499068,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-29T20:43:05.000Z","date":"2024-05-25","kind":"exercise","planned":false,"acquired":true,"shares":8636,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."}],"balance_after":13291,"source":{"system":"sec-edgar","filing":"0001447362-24-000094","document":"wk-form4_1717015375.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000094/wk-form4_1717015375.xml","form_type":"4"}},{"id":1500299,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-28T20:06:49.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":8673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSU's vest in full on the one-year anniversary of the date of grant on May 23, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSU's vest in full on the one-year anniversary of the date of grant on May 23, 2025."}],"balance_after":8673,"derivative":{"underlying":"Common Stock","underlying_shares":8673},"source":{"system":"sec-edgar","filing":"0001447362-24-000076","document":"wk-form4_1716926801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000076/wk-form4_1716926801.xml","form_type":"4"}},{"id":1839763,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-07-03T20:15:09.000Z","date":"2023-06-29","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in a single installment on June 29, 2023; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in a single installment on June 29, 2023; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-23-010560","document":"form4-07032023_040703.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588923010560/form4-07032023_040703.xml","form_type":"4"}},{"id":1839762,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Share","published_at":"2023-07-03T20:15:09.000Z","date":"2023-06-29","kind":"exercise","planned":false,"acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001415889-23-010560","document":"form4-07032023_040703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588923010560/form4-07032023_040703.xml","form_type":"4"}},{"id":1862465,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-06-08T20:20:44.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":4373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary of the date of the grant, June 6, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary of the date of the grant, June 6, 2023."}],"balance_after":4373,"derivative":{"underlying":"Class A Common Shares","underlying_shares":4373},"source":{"system":"sec-edgar","filing":"0001415889-23-009424","document":"form4-06082023_080641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588923009424/form4-06082023_080641.xml","form_type":"4"}},{"id":1862464,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2023-06-08T20:20:44.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":26236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant. The date of the grant is June 6, 2023."}],"balance_after":26236,"derivative":{"exercise_price":15.19,"expiration_date":"2033-06-05","underlying":"Class A Common Shares","underlying_shares":26236},"source":{"system":"sec-edgar","filing":"0001415889-23-009424","document":"form4-06082023_080641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588923009424/form4-06082023_080641.xml","form_type":"4"}},{"id":1865079,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-06T20:40:25.000Z","date":"2023-06-02","kind":"exercise","planned":false,"acquired":false,"shares":3825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on the one-year anniversary of the date of grant on June 2, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on the one-year anniversary of the date of grant on June 2, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3825},"source":{"system":"sec-edgar","filing":"0001447362-23-000105","document":"wk-form4_1686084005.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736223000105/wk-form4_1686084005.xml","form_type":"4"}},{"id":1865078,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T20:40:25.000Z","date":"2023-06-02","kind":"exercise","planned":false,"acquired":true,"shares":3825,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."}],"balance_after":4655,"source":{"system":"sec-edgar","filing":"0001447362-23-000105","document":"wk-form4_1686084005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736223000105/wk-form4_1686084005.xml","form_type":"4"}},{"id":1874737,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-30T21:48:59.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":8636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the one-year anniversary of the date of grant on May 25, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the one-year anniversary of the date of grant on May 25, 2024."}],"balance_after":8636,"derivative":{"underlying":"Common Stock","underlying_shares":8636},"source":{"system":"sec-edgar","filing":"0001447362-23-000086","document":"wk-form4_1685483321.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736223000086/wk-form4_1685483321.xml","form_type":"4"}},{"id":2218794,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-06-30T20:17:51.000Z","date":"2022-06-29","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary of the date of grant, June 29, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary of the date of grant, June 29, 2022."}],"balance_after":5000,"derivative":{"underlying":"Class A Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-22-007103","document":"form4-06302022_010640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588922007103/form4-06302022_010640.xml","form_type":"4"}},{"id":2218793,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2022-06-30T20:17:51.000Z","date":"2022-06-29","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of grant. The date of grant is June 29, 2022."}],"balance_after":30000,"derivative":{"exercise_price":9.88,"expiration_date":"2032-06-28","underlying":"Class A Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001415889-22-007103","document":"form4-06302022_010640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588922007103/form4-06302022_010640.xml","form_type":"4"}},{"id":2234087,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-13T23:05:33.000Z","date":"2022-06-10","kind":"exercise","acquired":false,"shares":830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on the one-year anniversary of the date of grant on June 10, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on the one-year anniversary of the date of grant on June 10, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":830},"source":{"system":"sec-edgar","filing":"0001447362-22-000117","document":"wf-form4_165516151693035.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736222000117/wf-form4_165516151693035.xml","form_type":"4"}},{"id":2234086,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T23:05:33.000Z","date":"2022-06-10","kind":"exercise","acquired":true,"shares":830,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":830,"source":{"system":"sec-edgar","filing":"0001447362-22-000117","document":"wf-form4_165516151693035.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736222000117/wf-form4_165516151693035.xml","form_type":"4"}},{"id":2242237,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-06T23:13:58.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":3825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the one-year anniversary of the date of grant on June 2, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the one-year anniversary of the date of grant on June 2, 2023."}],"balance_after":3825,"derivative":{"underlying":"Common Stock","underlying_shares":3825},"source":{"system":"sec-edgar","filing":"0001447362-22-000100","document":"wf-form4_165455722481109.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736222000100/wf-form4_165455722481109.xml","form_type":"4"}},{"id":2242236,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-06-06T23:13:58.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":7647,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7647,"derivative":{"exercise_price":20.77,"exercise_date":"2023-06-02","expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":7647},"source":{"system":"sec-edgar","filing":"0001447362-22-000100","document":"wf-form4_165455722481109.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736222000100/wf-form4_165455722481109.xml","form_type":"4"}},{"id":2650179,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2021-06-30T20:20:35.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":33237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of grant. The date of grant is June 29, 2021."}],"balance_after":33237,"derivative":{"exercise_price":14.33,"expiration_date":"2031-06-28","underlying":"Class A Common Shares","underlying_shares":33237},"source":{"system":"sec-edgar","filing":"0001179110-21-007181","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000117911021007181/edgar.xml","form_type":"4"}},{"id":2670064,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-14T20:29:25.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the one-year anniversary of the date of grant on June 10, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the one-year anniversary of the date of grant on June 10, 2022."}],"balance_after":830,"derivative":{"underlying":"Common Stock","underlying_shares":830},"source":{"system":"sec-edgar","filing":"0001447362-21-000140","document":"wf-form4_162370255122954.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736221000140/wf-form4_162370255122954.xml","form_type":"4"}},{"id":2670063,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-06-14T20:29:25.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":3379,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3379,"derivative":{"exercise_price":71.22,"exercise_date":"2022-06-10","expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":3379},"source":{"system":"sec-edgar","filing":"0001447362-21-000140","document":"wf-form4_162370255122954.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736221000140/wf-form4_162370255122954.xml","form_type":"4"}},{"id":3074138,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2020-07-29T21:46:13.000Z","date":"2020-07-27","kind":"grant","acquired":true,"shares":37965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to one third of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a twenty-four month period thereafter. The vesting commencement date is July 27, 2020."}],"balance_after":37965,"derivative":{"exercise_price":20.09,"expiration_date":"2030-07-26","underlying":"Class A Common Shares","underlying_shares":37965},"source":{"system":"sec-edgar","filing":"0001179110-20-008544","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000117911020008544/edgar.xml","form_type":"4"}},{"id":3118610,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-06-08T16:28:44.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8000,"derivative":{"exercise_price":37.5,"exercise_date":"2021-06-04","expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001447362-20-000113","document":"wf-form4_159163370513906.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736220000113/wf-form4_159163370513906.xml","form_type":"4"}},{"id":3256939,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Manager - Diagnostics"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-21T16:58:27.000Z","date":"2020-02-19","kind":"exercise","acquired":false,"shares":13422,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":35.91,"exercise_date":"2019-11-11","expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":13422},"source":{"system":"sec-edgar","filing":"0001209191-20-011595","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919120011595/doc4.xml","form_type":"4"}},{"id":3256938,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Manager - Diagnostics"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-21T16:58:27.000Z","date":"2020-02-19","kind":"exercise","acquired":false,"shares":3934,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":35.28,"exercise_date":"2019-11-11","expiration_date":"2026-02-16","underlying":"Common Stock","underlying_shares":3934},"source":{"system":"sec-edgar","filing":"0001209191-20-011595","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919120011595/doc4.xml","form_type":"4"}},{"id":3256937,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Manager - Diagnostics"}}],"security":"Common Stock","published_at":"2020-02-21T16:58:27.000Z","date":"2020-02-19","kind":"sale","acquired":false,"shares":27356,"price":100,"value":2735600.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"In addition to the shares of Common Stock reported on this Form 4, which total 10,194 shares, Mr. Cole also holds, in the aggregate, an additional 53,377 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock."}],"balance_after":10194,"source":{"system":"sec-edgar","filing":"0001209191-20-011595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919120011595/doc4.xml","form_type":"4"}},{"id":3256936,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Manager - Diagnostics"}}],"security":"Common Stock","published_at":"2020-02-21T16:58:27.000Z","date":"2020-02-19","kind":"exercise","acquired":true,"shares":13422,"price":35.91,"value":481984.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received upon exercise of a stock option award."}],"balance_after":37550,"source":{"system":"sec-edgar","filing":"0001209191-20-011595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919120011595/doc4.xml","form_type":"4"}},{"id":3256935,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Manager - Diagnostics"}}],"security":"Common Stock","published_at":"2020-02-21T16:58:27.000Z","date":"2020-02-19","kind":"exercise","acquired":true,"shares":3934,"price":35.28,"value":138791.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received upon exercise of a stock option award."}],"balance_after":24128,"source":{"system":"sec-edgar","filing":"0001209191-20-011595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919120011595/doc4.xml","form_type":"4"}},{"id":3308227,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Manager - Diagnostics"}}],"security":"Common Stock","published_at":"2020-01-17T16:50:44.000Z","date":"2020-01-16","kind":"sale","acquired":false,"shares":10000,"price":90.3,"value":903000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In addition to the shares of Common Stock reported on this Form 4, which total 20,987 shares, Mr. Cole also holds, in the aggregate, an additional 70,733 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock."}],"balance_after":8653,"source":{"system":"sec-edgar","filing":"0001209191-20-004038","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919120004038/doc4.xml","form_type":"4"}},{"id":3334084,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Manager - Diagnostics"}}],"security":"Restricted Stock Units","published_at":"2019-12-20T16:17:24.000Z","date":"2019-12-18","kind":"grant","acquired":true,"shares":9620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units vest in full on December 31, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units vest in full on December 31, 2020."}],"balance_after":9620,"derivative":{"underlying":"Common Stock","underlying_shares":9620},"source":{"system":"sec-edgar","filing":"0001209191-19-061534","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919119061534/doc4.xml","form_type":"4"}},{"id":3334083,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Manager - Diagnostics"}}],"security":"Common Stock","published_at":"2019-12-20T16:17:24.000Z","date":"2019-12-04","kind":"gift","acquired":false,"shares":12334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In addition to the shares of Common Stock reported on this Form 4, which total 30,987 shares, Mr. Cole also holds, in the aggregate, an additional 70,733 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock."}],"balance_after":18653,"source":{"system":"sec-edgar","filing":"0001209191-19-061534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919119061534/doc4.xml","form_type":"4"}},{"id":3360165,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Manager - Diagnostics"}}],"security":"Common Stock","published_at":"2019-11-25T17:18:42.000Z","date":"2019-11-21","kind":"sale","acquired":false,"shares":28016,"price":80.38,"value":2251926.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to a Sell-to-Cover 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain stock options and restricted stock units on February 8, 2019."}],"balance_after":30987,"source":{"system":"sec-edgar","filing":"0001209191-19-057962","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919119057962/doc4.xml","form_type":"4"}},{"id":3371595,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy) Holding","published_at":"2019-11-14T21:39:27.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":27740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 21,230 shares of Exact Sciences common stock with an exercise price of $94.76 per share."}],"balance_after":0,"derivative":{"exercise_price":72.52,"expiration_date":"2029-01-29","underlying":"Common Stock","underlying_shares":27740},"source":{"system":"sec-edgar","filing":"0001209191-19-056631","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056631/doc4.xml","form_type":"4"}},{"id":3371594,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy) Holding","published_at":"2019-11-14T21:39:27.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":29436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 22,528 shares of Exact Sciences common stock with an exercise price of $43.40 per share."}],"balance_after":0,"derivative":{"exercise_price":33.21,"expiration_date":"2028-01-31","underlying":"Common Stock","underlying_shares":29436},"source":{"system":"sec-edgar","filing":"0001209191-19-056631","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056631/doc4.xml","form_type":"4"}},{"id":3371593,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy) Holding","published_at":"2019-11-14T21:39:27.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":22894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $316,752, less applicable tax withholdings, and 5,188 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":29436,"derivative":{"exercise_price":33.21,"expiration_date":"2028-01-31","underlying":"Common Stock","underlying_shares":22894},"source":{"system":"sec-edgar","filing":"0001209191-19-056631","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056631/doc4.xml","form_type":"4"}},{"id":3371592,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy) Holding","published_at":"2019-11-14T21:39:27.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":17538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 13,422 shares of Exact Sciences common stock with an exercise price of $35.91 per share."}],"balance_after":0,"derivative":{"exercise_price":27.48,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":17538},"source":{"system":"sec-edgar","filing":"0001209191-19-056631","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056631/doc4.xml","form_type":"4"}},{"id":3371591,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy) Holding","published_at":"2019-11-14T21:39:27.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":38582,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $624,767 less applicable tax withholdings, and 10,233 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":17538,"derivative":{"exercise_price":27.48,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":38582},"source":{"system":"sec-edgar","filing":"0001209191-19-056631","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056631/doc4.xml","form_type":"4"}},{"id":3371590,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy) Holding","published_at":"2019-11-14T21:39:27.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":5142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 3,935 shares of Exact Sciences common stock with an exercise price of $35.28 per share."}],"balance_after":0,"derivative":{"exercise_price":27,"expiration_date":"2026-02-16","underlying":"Common Stock","underlying_shares":5142},"source":{"system":"sec-edgar","filing":"0001209191-19-056631","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056631/doc4.xml","form_type":"4"}},{"id":3371589,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy) Holding","published_at":"2019-11-14T21:39:27.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":56558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $927,027, less applicable tax withholdings, and 15,184 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":5142,"derivative":{"exercise_price":27,"expiration_date":"2026-02-16","underlying":"Common Stock","underlying_shares":56558},"source":{"system":"sec-edgar","filing":"0001209191-19-056631","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056631/doc4.xml","form_type":"4"}},{"id":3371588,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy) Holding","published_at":"2019-11-14T21:39:27.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $808,254, less applicable tax withholdings, and 13,238 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":0,"derivative":{"exercise_price":31.12,"expiration_date":"2025-02-13","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-19-056631","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056631/doc4.xml","form_type":"4"}},{"id":3371587,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-11-14T21:39:27.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $296,215, less applicable tax withholdings, and 4,851 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":0,"derivative":{"exercise_price":30.84,"expiration_date":"2024-01-28","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-056631","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056631/doc4.xml","form_type":"4"}},{"id":3371586,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-11-14T21:39:27.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":1888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $30,130, less applicable tax withholdings, and 493 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":0,"derivative":{"exercise_price":28.05,"expiration_date":"2023-01-31","underlying":"Common Stock","underlying_shares":1888},"source":{"system":"sec-edgar","filing":"0001209191-19-056631","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056631/doc4.xml","form_type":"4"}},{"id":3371585,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-11-14T21:39:27.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":11794,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Disposed of in connection with the Merger, whereby such Issuer resticted stock unit (\"RSU\") was assumed by Exact Sciences and converted into a corresponding award for 9,026 RSUs of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-056631","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056631/doc4.xml","form_type":"4"}},{"id":3371584,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-11-14T21:39:27.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":27385,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of in connection with the acquisition of Issuer (the \"Merger\") by Exact Sciences Corporation (\"Exact Sciences\") pursuant to the Agreement and Plan of Merger, dated July 28, 2019 (the \"Merger Agreement\"), among Exact Sciences,Spring Acquisition Corp., and Issuer, whereby such shares of Issuer common stock were cancelled and converted into the right to receive a cash payment of $753,089 and 12,335 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":11794,"source":{"system":"sec-edgar","filing":"0001209191-19-056631","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056631/doc4.xml","form_type":"4"}},{"id":3395495,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-10-09T17:10:25.000Z","date":"2019-10-07","kind":"exercise","acquired":false,"shares":22560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option became exercisable as to 25% of the shares on January 28, 2015, and became exercisable as to 1/48th of the shares each full month thereafter."}],"balance_after":20000,"derivative":{"exercise_price":30.84,"expiration_date":"2024-01-28","underlying":"Common Stock","underlying_shares":22560},"source":{"system":"sec-edgar","filing":"0001209191-19-052834","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119052834/doc4.xml","form_type":"4"}},{"id":3395494,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-10-09T17:10:25.000Z","date":"2019-10-07","kind":"sale","acquired":false,"shares":22560,"price":69.0109,"value":1556885.904,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sale price. Actual sale prices ranged from $68.66 to $69.31."}],"balance_after":38970,"source":{"system":"sec-edgar","filing":"0001209191-19-052834","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119052834/doc4.xml","form_type":"4"}},{"id":3395493,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-10-09T17:10:25.000Z","date":"2019-10-07","kind":"exercise","acquired":true,"shares":22560,"price":30.84,"value":695750.4,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":61530,"source":{"system":"sec-edgar","filing":"0001209191-19-052834","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119052834/doc4.xml","form_type":"4"}},{"id":3417747,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-09-11T16:16:09.000Z","date":"2019-09-10","kind":"exercise","acquired":false,"shares":18112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option became exercisable as to 25% of the shares on January 31, 2014, and became exercisable as to 1/48th of the shares each full month thereafter."}],"balance_after":1888,"derivative":{"exercise_price":28.05,"expiration_date":"2023-01-31","underlying":"Common Stock","underlying_shares":18112},"source":{"system":"sec-edgar","filing":"0001209191-19-049152","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119049152/doc4.xml","form_type":"4"}},{"id":3417746,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-09-11T16:16:09.000Z","date":"2019-09-09","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option became exercisable as to 25% of the shares on January 31, 2014, and became exercisable as to 1/48th of the shares each full month thereafter."}],"balance_after":20000,"derivative":{"exercise_price":28.05,"expiration_date":"2023-01-31","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-049152","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119049152/doc4.xml","form_type":"4"}},{"id":3417745,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-09-11T16:16:09.000Z","date":"2019-09-10","kind":"sale","acquired":false,"shares":4809,"price":72.3328,"value":347848.4352,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents weighted average sale price. Actual sale prices ranged from $72.07 to $72.60."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":38970,"source":{"system":"sec-edgar","filing":"0001209191-19-049152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119049152/doc4.xml","form_type":"4"}},{"id":3417744,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-09-11T16:16:09.000Z","date":"2019-09-10","kind":"sale","acquired":false,"shares":13303,"price":71.595,"value":952428.285,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents weighted average sale price. Actual sale prices ranged from $71.07 to $72.06."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":43779,"source":{"system":"sec-edgar","filing":"0001209191-19-049152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119049152/doc4.xml","form_type":"4"}},{"id":3417743,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-09-11T16:16:09.000Z","date":"2019-09-10","kind":"exercise","acquired":true,"shares":18112,"price":28.05,"value":508041.6,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":57082,"source":{"system":"sec-edgar","filing":"0001209191-19-049152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119049152/doc4.xml","form_type":"4"}},{"id":3417742,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-09-11T16:16:09.000Z","date":"2019-09-09","kind":"sale","acquired":false,"shares":1762,"price":74.0022,"value":130391.8764,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents weighted average sale price. Actual sale prices ranged from $73.69 to $74.46."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":38970,"source":{"system":"sec-edgar","filing":"0001209191-19-049152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119049152/doc4.xml","form_type":"4"}},{"id":3417741,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-09-11T16:16:09.000Z","date":"2019-09-09","kind":"sale","acquired":false,"shares":5707,"price":73.3509,"value":418613.5863,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents weighted average sale price. Actual sale prices ranged from $72.69 to $73.67."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":40732,"source":{"system":"sec-edgar","filing":"0001209191-19-049152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119049152/doc4.xml","form_type":"4"}},{"id":3417740,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-09-11T16:16:09.000Z","date":"2019-09-09","kind":"sale","acquired":false,"shares":17531,"price":72.1046,"value":1264065.7426,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sale price. Actual sale prices ranged from $71.69 to $72.67."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":46439,"source":{"system":"sec-edgar","filing":"0001209191-19-049152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119049152/doc4.xml","form_type":"4"}},{"id":3417739,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-09-11T16:16:09.000Z","date":"2019-09-09","kind":"exercise","acquired":true,"shares":25000,"price":28.05,"value":701250.0,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":63970,"source":{"system":"sec-edgar","filing":"0001209191-19-049152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119049152/doc4.xml","form_type":"4"}},{"id":3438942,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-08-14T16:22:10.000Z","date":"2019-08-12","kind":"exercise","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option became exercisable as to 25% of the shares on February 3, 2013, and became exercisable as to 1/48th of the shares each full month thereafter."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"The option became exercisable as to 25% of the shares on February 3, 2013, and became exercisable as to 1/48th of the shares each full month thereafter."}],"balance_after":0,"derivative":{"exercise_price":29.34,"expiration_date":"2022-02-03","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-19-045900","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119045900/doc4.xml","form_type":"4"}},{"id":3438941,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-08-14T16:22:10.000Z","date":"2019-08-12","kind":"sale","acquired":false,"shares":1225,"price":73.7516,"value":90345.71,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 1, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":38970,"source":{"system":"sec-edgar","filing":"0001209191-19-045900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119045900/doc4.xml","form_type":"4"}},{"id":3438940,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-08-14T16:22:10.000Z","date":"2019-08-12","kind":"sale","acquired":false,"shares":58775,"price":73.3006,"value":4308242.765,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sale price. Actual sale prices ranged from $72.73 to $73.72."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Represents weighted average sale price. Actual sale prices ranged from $73.74 to $73.83."}],"balance_after":40195,"source":{"system":"sec-edgar","filing":"0001209191-19-045900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119045900/doc4.xml","form_type":"4"}},{"id":3438939,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-08-14T16:22:10.000Z","date":"2019-08-12","kind":"exercise","acquired":true,"shares":60000,"price":29.34,"value":1760400.0,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":98970,"source":{"system":"sec-edgar","filing":"0001209191-19-045900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119045900/doc4.xml","form_type":"4"}},{"id":3438938,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-08-14T16:22:10.000Z","date":"2019-08-07","kind":"gift","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":38970,"source":{"system":"sec-edgar","filing":"0001209191-19-045900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119045900/doc4.xml","form_type":"4"}},{"id":3463776,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-07-11T18:13:32.000Z","date":"2019-07-09","kind":"exercise","acquired":false,"shares":6471,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option became exercisable as to 25% of the shares on February 18, 2011, and became exercisable as to 1/48th of the shares each full month thereafter."}],"balance_after":0,"derivative":{"exercise_price":17.18,"expiration_date":"2020-02-18","underlying":"Common Stock","underlying_shares":6471},"source":{"system":"sec-edgar","filing":"0001209191-19-041862","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119041862/doc4.xml","form_type":"4"}},{"id":3463775,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-07-11T18:13:32.000Z","date":"2019-07-09","kind":"sale","acquired":false,"shares":5033,"price":57.327,"value":288526.791,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 4, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents weighted average sale price. Actual sale prices ranged from $56.86 to $57.60."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":43970,"source":{"system":"sec-edgar","filing":"0001209191-19-041862","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119041862/doc4.xml","form_type":"4"}},{"id":3463774,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-07-11T18:13:32.000Z","date":"2019-07-09","kind":"sale","acquired":false,"shares":1438,"price":56.2302,"value":80859.0276,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 4, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sale price. Actual sale prices ranged from $55.83 to $56.60."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":49003,"source":{"system":"sec-edgar","filing":"0001209191-19-041862","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119041862/doc4.xml","form_type":"4"}},{"id":3463773,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-07-11T18:13:32.000Z","date":"2019-07-09","kind":"exercise","acquired":true,"shares":6471,"price":17.18,"value":111171.78,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":50441,"source":{"system":"sec-edgar","filing":"0001209191-19-041862","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119041862/doc4.xml","form_type":"4"}},{"id":3491629,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-06-13T19:31:52.000Z","date":"2019-06-11","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option became exercisable as to 25% of the shares on February 18, 2011, and became exercisable as to 1/48th of the shares each full month thereafter."}],"balance_after":6471,"derivative":{"exercise_price":17.18,"expiration_date":"2020-02-18","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-036949","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119036949/doc4.xml","form_type":"4"}},{"id":3491628,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-06-13T19:31:52.000Z","date":"2019-06-11","kind":"sale","acquired":false,"shares":770,"price":52.3412,"value":40302.724,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 4, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents weighted average sale price. Actual sale prices ranged from $51.93 to $52.61."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":43722,"source":{"system":"sec-edgar","filing":"0001209191-19-036949","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119036949/doc4.xml","form_type":"4"}},{"id":3491627,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-06-13T19:31:52.000Z","date":"2019-06-11","kind":"sale","acquired":false,"shares":4230,"price":51.2952,"value":216978.696,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 4, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sale price. Actual sale prices ranged from $50.93 to $51.91."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":44492,"source":{"system":"sec-edgar","filing":"0001209191-19-036949","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119036949/doc4.xml","form_type":"4"}},{"id":3491626,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-06-13T19:31:52.000Z","date":"2019-06-11","kind":"exercise","acquired":true,"shares":5000,"price":17.18,"value":85900.0,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":48722,"source":{"system":"sec-edgar","filing":"0001209191-19-036949","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119036949/doc4.xml","form_type":"4"}},{"id":3526228,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-05-15T16:55:28.000Z","date":"2019-05-14","kind":"exercise","acquired":false,"shares":6424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option became exercisable as to 25% of the shares on January 27, 2012, and became exercisable as to 1/48th of the shares each full month thereafter."}],"balance_after":0,"derivative":{"exercise_price":22.98,"expiration_date":"2021-01-27","underlying":"Common Stock","underlying_shares":6424},"source":{"system":"sec-edgar","filing":"0001209191-19-030060","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119030060/doc4.xml","form_type":"4"}},{"id":3526227,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-05-15T16:55:28.000Z","date":"2019-05-14","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option became exercisable as to 25% of the shares on February 18, 2011, and became exercisable as to 1/48th of the shares each full month thereafter."}],"balance_after":11471,"derivative":{"exercise_price":17.18,"expiration_date":"2020-02-18","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-030060","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119030060/doc4.xml","form_type":"4"}},{"id":3526226,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-05-15T16:55:28.000Z","date":"2019-05-14","kind":"sale","acquired":false,"shares":4674,"price":57.3606,"value":268103.4444,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 23 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents weighted average sale price. Actual sale prices ranged from $57.05 to $57.61."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":43722,"source":{"system":"sec-edgar","filing":"0001209191-19-030060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119030060/doc4.xml","form_type":"4"}},{"id":3526225,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-05-15T16:55:28.000Z","date":"2019-05-14","kind":"sale","acquired":false,"shares":1750,"price":56.6649,"value":99163.575,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 23 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents weighted average sale price. Actual sale prices ranged from $56.04 to $57.02."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":48396,"source":{"system":"sec-edgar","filing":"0001209191-19-030060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119030060/doc4.xml","form_type":"4"}},{"id":3526224,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-05-15T16:55:28.000Z","date":"2019-05-14","kind":"exercise","acquired":true,"shares":6424,"price":22.98,"value":147623.52,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":50146,"source":{"system":"sec-edgar","filing":"0001209191-19-030060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119030060/doc4.xml","form_type":"4"}},{"id":3526223,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-05-15T16:55:28.000Z","date":"2019-05-14","kind":"sale","acquired":false,"shares":4000,"price":57.3413,"value":229365.2,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 4, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents weighted average sale price. Actual sale prices ranged from $57.02 to $57.68."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":43722,"source":{"system":"sec-edgar","filing":"0001209191-19-030060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119030060/doc4.xml","form_type":"4"}},{"id":3526222,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-05-15T16:55:28.000Z","date":"2019-05-14","kind":"sale","acquired":false,"shares":1000,"price":56.52,"value":56520.0,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 4, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sale price. Actual sale prices ranged from $56.01 to $56.95."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":47722,"source":{"system":"sec-edgar","filing":"0001209191-19-030060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119030060/doc4.xml","form_type":"4"}},{"id":3526221,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-05-15T16:55:28.000Z","date":"2019-05-14","kind":"exercise","acquired":true,"shares":5000,"price":17.18,"value":85900.0,"ownership":{"direct":false,"nature":"Held by the Cole Family Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":48722,"source":{"system":"sec-edgar","filing":"0001209191-19-030060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119030060/doc4.xml","form_type":"4"}},{"id":3557876,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":27498,"kind":"person","name":"Cole G Bradley","position":1,"cik":"0001337798","reported_name":"Cole G Bradley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-04-11T18:11:10.000Z","date":"2019-04-09","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option became exercisable as to 25% of the shares on January 27, 2012, and became exercisable as to 1/48th of the shares each full month thereafter."}],"balance_after":6424,"derivative":{"exercise_price":22.98,"expiration_date":"2021-01-27","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-024397","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119024397/doc4.xml","form_type":"4"}}],"next_cursor":"2019-04-11T18:11:10.000000Z,3557876"}